Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn how Us Market Index Funds Retirement 2024 provides core exposure to the U.S. market. Compare funds and refine your retirement allocation.
28,197 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
Fintech down this year has pressured growth equities, yet cybersecurity ETFs are delivering relative steadiness as co...
Geopolitical tensions and a push for domestic fuel production are reshaping energy markets. The next energy superpowe...
A reader invites a friend to act as an informal adviser, only to learn the friend is paid to push certain funds. The ...
When celebrities team up to write, the money story is almost as compelling as the pages. This article breaks down how...
When a stock climbs 250% in a year, funds often trim positions to lock in gains and manage risk. This article explain...
A landmark joint interpretive guidance from the SEC and CFTC clarifies crypto regulation, focusing on security classi...
Over the last year, ISCV outpaced IJJ, but market cycles can change on a dime. This guide explains why that edge may ...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...